Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II FLUad 2008-2009 influenza vaccine study in elderly subjects
2008-001047-19Phase 2Completed
- Sponsor
- Novartis
- Start
- May 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Fluzone Trivalent in influenza, sponsored by Novartis. Primary endpoints: Seroconversion or significant increase in anti-HA antibody titer, Mean geometric increase in antibody titer and 4 more. Started May 2009; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on 2008-001047-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001047-19.